EconomyNovo CEO signals M&A opportunities to strengthen drug pipeline
Novo Nordisk CEO Mike Doustdar told CNBC that the company is considering merger and acquisition opportunities to reinforce its drug pipeline as competition in the weight-loss market intensifies.
C
CNBC★★☆☆☆2026-09-22 09:00Original
Novo CEO signals M&A opportunities to strengthen drug pipeline
Economy